BiotechTubeBiotechTube
Home/Oculis Holding AG/David H. Moore, J.D.
DH

David H. Moore, J.D.

Chief Legal Officer and Corporate Secretary

Oculis Holding AG

Therapeutic Areas

OphthalmologyRetinal DiseasesOcular InflammationNeuro-ophthalmology

Oculis Holding AG Pipeline

DrugIndicationPhase
OCS-01Diabetic Macular Edema (DME)Phase 3
OCS-02 (licaminlimab)Dry Eye Disease (DED)Phase 2b/3
OCS-05Acute Optic Neuritis (AON)Phase 1

Leadership Team at Oculis Holding AG

RS
Riad Sherif, M.D.
Chief Executive Officer and Director
RM
R. Michael Gendreau, M.D., Ph.D.
Chief Medical Officer
SC
Sylvia Cheung, CPA
Chief Financial Officer
PF
Patricia F. Walker, M.D., Ph.D.
Chief Scientific Officer
CA
Christina Ackermann
Chief Operating Officer
ED
Eric D. Donnenfeld, M.D.
Chairman of the Board
AY
Anthony Y. Sun, M.D.
Director
CM
Catherine Mazzacco
Director
LS
Laurie Smaldone Alsup, M.D.
Director
GO
Geraldine O'Keeffe
Director
View full Oculis Holding AG profile